Regent Pacific Group Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RPGLF research report →
About the company
Regent Pacific Group Limited operates as an investment holding company, directing capital towards businesses within the healthcare and life sciences sectors, primarily in European and Taiwanese markets. The company's activities are organized into two primary divisions: Biopharma and Corporate Investment. Within the Biopharma segment, the focus is on the entire lifecycle of pharmaceutical products, from initial research and development to manufacturing, marketing, and sales, specifically addressing treatments for urological conditions.
- CEO
- Jamie Alexander Gibson
- IPO
- 1997
- Employees
- 13
- HQ
- Central, HK
Price Chart
- Market Cap
- $1.72M
- P/E
- -7.75
- P/S
- 100.43
- P/B
- -5.50
- EV/EBITDA
- -9.38
- Div Yield
- 0.00%
- Gross Margin
- -115.70%
- Op Margin
- -1187.88%
- Net Margin
- -1297.52%
- ROE
- 87.15%
- ROIC
- -754.58%
- Revenue
- $348.51K · -51.53%
- Net Income
- $-4,716,967 · -5.24%
- EPS
- $-0.02 · 8.16%
- Op Income
- $-4,318,378
- FCF YoY
- -4.11%
- 52W High
- $0.43
- 52W Low
- $0.00
- 50D MA
- $0.01
- 200D MA
- $0.09
- Beta
- 1.19
- Avg Volume
- 2.20K
Get TickerSpark's AI analysis on RPGLF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our RPGLF coverage
Recent articles, reports, and earnings notes.
No research on RPGLF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate RPGLF report →Similar companies
Peers in the same neighborhood.